The independent source for health policy research, polling, and news.
May 26, 2021
With news that the country has now vaccinated half of its population with at least one dose, This Drew Altman Axios column highlights the persistent COVID-19 vaccine myths that are believed by a substantial portion of the unvaccinated population and discusses the options to address vaccine misinformation.
Column Read PostMay 25, 2021
In this op-ed for The Washington Post, Drew Altman suggests a way out of the heated debate about a COVID-19 vaccination passport to help provide clarity about who is vaccinated and who still ought to wear masks in public spaces or the workplace by using something that already exists– CDC vaccination cards.
Op-Ed Read PostApril 29, 2021
In this Axios column, Drew Altman explores whether the long struggle with rising health costs has caused the tide to turn in corporate leaders’ attitudes towards government involvement in controlling health spending and whether it is part of a larger shift in comfort with government action to solve problems.
Column Read PostApril 5, 2021
In this Axios column, Drew Altman examines why doctors and nurses are such critical messengers in the effort to build vaccine confidence.
Column Read PostMarch 31, 2021
In an op-ed for The Washington Post, Drew Altman spells out how COVID-19 vaccination can be simplified to ensure that the public’s rising confidence in the vaccine isn’t thwarted by frustrating and sometimes dysfunctional websites.
Op-Ed Read PostMarch 22, 2021
In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them.” But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of ‘wait and see’ Americans.”
Column Read Post